Cargando…
Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to be a global threat since its emergence. Although several COVID-19 vaccines have become available, the prospective timeframe for achieving effective levels of vaccination across g...
Autores principales: | Zhu, Wei, Shyr, Zeenat, Lo, Donald C., Zheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686716/ https://www.ncbi.nlm.nih.gov/pubmed/33972366 http://dx.doi.org/10.1124/jpet.121.000688 |
Ejemplares similares
-
Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020) -
Drug combination therapy for emerging viral diseases
por: Shyr, Zeenat A., et al.
Publicado: (2021) -
Coronavirus disease 2019 and renal transplantation
por: Nassar, Mahmoud, et al.
Publicado: (2021) -
Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury
por: Han, Mei-Wen, et al.
Publicado: (2021) -
Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects
por: Loinaz-Segurola, Carmelo, et al.
Publicado: (2021)